LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Walenga, Jeanine"
  2. AU="Niania, Wiremu"

Search results

Result 1 - 10 of total 204

Search options

  1. Book: Rodak's hematology

    Keohane, Elaine M. / Walenga, Jeanine M. / Otto, Catherine M.

    clinical principles and applications

    2020  

    Title variant Hematology
    Author's details Elaine M. Keohane, Catherine N. Otto, Jeanine M. Walenga
    Keywords Hematologic Diseases / diagnosis ; Blood Cells / physiology ; Hematologic Tests / methods ; Hematopoiesis ; Hemostasis
    Language English
    Size xv, 887 Seiten, Illustrationen
    Edition Sixth edition
    Publisher Elsevier
    Publishing place St. Louis, Missouri
    Publishing country United States
    Document type Book
    Note Zugang zur Online-Ausgabe über Code
    HBZ-ID HT020123620
    ISBN 978-0-323-53045-3 ; 0-323-53045-1
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book ; Conference proceedings: Landmarks in anti thrombin drug development

    Walenga, Jeanine M.

    the Argatroban story ; [includes the proceedings of the Symposium Landmarks in Anti-Thrombin Drug Development: The Argatroban Story ... held on July 11, 2007 ... in Geneva, Switzerland]

    (Seminars in thrombosis and hemostasis ; 34, Suppl. 1)

    2008  

    Title variant Landmarks in anti-thrombin drug development
    Event/congress Symposium Landmarks in Anti-Thrombin Drug Development: The Argatroban Story (2007, Genf)
    Author's details guest ed. Jeanine M. Walenga
    Series title Seminars in thrombosis and hemostasis ; 34, Suppl. 1
    Collection
    Language English
    Size III, 129 S. : Ill., graph. Darst.
    Publisher Thieme Med. Publ
    Publishing place New York
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT015772355
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Can We Improve on the Rapid Assessment of Clinically Relevant Levels of Direct Acting Oral Anticoagulants (DOAC)?

    Walenga, Jeanine M

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    2022  Volume 28, Page(s) 10760296221096422

    MeSH term(s) Administration, Oral ; Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Factor Xa Inhibitors/pharmacology ; Factor Xa Inhibitors/therapeutic use ; Humans
    Chemical Substances Anticoagulants ; Factor Xa Inhibitors
    Language English
    Publishing date 2022-04-26
    Publishing country United States
    Document type Editorial
    ZDB-ID 1237357-6
    ISSN 1938-2723 ; 1076-0296
    ISSN (online) 1938-2723
    ISSN 1076-0296
    DOI 10.1177/10760296221096422
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Rodak's hematology

    Keohane, Elaine M. / Smith, Larry J. / Walenga, Jeanine M. / Rodak, Bernadette F.

    clinical principles and applications

    2016  

    Title variant Hematology
    Author's details Elaine M. Keohane ; Larry J. Smith ; Jeanine M. Walenga
    Keywords Hematologic Diseases / diagnosis ; Blood Cells / physiology ; Hematologic Tests / methods ; Hematopoiesis ; Hemostasis
    Language English
    Size XIV, 898 S. : Ill., graph. Darst.
    Edition 5. ed.
    Publisher Elsevier
    Publishing place St. Louis, Mo
    Publishing country United States
    Document type Book
    Note Preceded by Hematology : clinical principles and applications / [edited by] Bernadette F. Rodak, George A. Fritsma, Elaine M. Keohane. 4th ed. c2012 ; Includes bibliographical references and index
    HBZ-ID HT018610087
    ISBN 978-0-323-23906-6 ; 0-323-23906-4
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Article: Heparin: Much more than anti-IIa/anti-Xa.

    Walenga, Jeanine M

    Journal de medecine vasculaire

    2020  Volume 45, Issue 3, Page(s) 103–104

    MeSH term(s) Anticoagulants ; Heparin ; Heparin, Low-Molecular-Weight ; Humans
    Chemical Substances Anticoagulants ; Heparin, Low-Molecular-Weight ; Heparin (9005-49-6)
    Language English
    Publishing date 2020-03-27
    Publishing country France
    Document type Editorial ; Comment
    ISSN 2542-4513
    ISSN 2542-4513
    DOI 10.1016/j.jdmv.2020.03.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book: Heparin induced thrombocytopenia

    Walenga, Jeanine M.

    [compilation of selected presentations ... from two symposia held on December 6, 1996 ... in Orlando, FL and held on June 12, 1997 ... in Florence, Italy]

    (Seminars in thrombosis and hemostasis ; 25, Suppl. 1)

    1999  

    Title variant Heparin-induced
    Author's details Jeanine M. Walenga, ... guest ed
    Series title Seminars in thrombosis and hemostasis ; 25, Suppl. 1
    Collection
    Language English
    Size 81 S. : graph. Darst.
    Publisher Thieme Med. Publ
    Publishing place New York u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT010501145
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  7. Book ; Conference proceedings: Development of non-heparin glycosaminoglycans as therapeutic agents / [1]

    Walenga, Jeanine M.

    [symposium Maywood, Illinois, in May, 1989]

    (Seminars in thrombosis and hemostasis ; 17, Suppl. 1)

    1991  

    Author's details Jeanine M. Walenga ..., guest ed
    Series title Seminars in thrombosis and hemostasis ; 17, Suppl. 1
    Development of non-heparin glycosaminoglycans as therapeutic agents
    Collection Development of non-heparin glycosaminoglycans as therapeutic agents
    Language English
    Size 135 S. : Ill., graph. Darst.
    Publisher Thieme Med
    Publishing place New York u.a.
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT003872199
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  8. Book ; Conference proceedings: Development of non-heparin glycosaminoglycans as therapeutic agents / 2

    Walenga, Jeanine M.

    [symposium Maywood, Illinois, in May, 1989]

    (Seminars in thrombosis and hemostasis ; 17, Suppl. 2)

    1991  

    Author's details Jeanine M. Walenga ..., guest ed
    Series title Seminars in thrombosis and hemostasis ; 17, Suppl. 2
    Development of non-heparin glycosaminoglycans as therapeutic agents
    Collection Development of non-heparin glycosaminoglycans as therapeutic agents
    Language English
    Size S. 137 - 245 : Ill., graph. Darst.
    Publisher Thieme Med
    Publishing place New York u.a.
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT003872357
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  9. Article ; Online: The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting.

    Vassart, Julie / Tafur, Alfonso / Durante, Marisa / Boucher, Anne-Yseult / Morimont, Laure / Walenga, Jeanine M / Harenberg, Job / Douxfils, Jonathan

    Thrombosis research

    2024  Volume 239, Page(s) 109023

    Language English
    Publishing date 2024-05-07
    Publishing country United States
    Document type Letter
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2024.04.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism.

    O'Hara, Alexander / Pozin, Jacob / Darki, Amir / Siddiqui, Fakiha / Hoppensteadt, Debra / Walenga, Jeanine / Fareed, Jawed / Kantarcioglu, Bulent

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

    2023  Volume 29, Page(s) 10760296231165058

    Abstract: Type I and type II diabetes are closely associated with a pro-inflammatory state and to a pro-thrombotic state. The role of glycemic control in pulmonary embolism (PE) is poorly understood and requires additional investigation. The aim of this study is ... ...

    Abstract Type I and type II diabetes are closely associated with a pro-inflammatory state and to a pro-thrombotic state. The role of glycemic control in pulmonary embolism (PE) is poorly understood and requires additional investigation. The aim of this study is to investigate the relationship between glycemic control and thrombo-inflammatory biomarkers in a PE patient cohort compared to normal samples. Demographic and clinical information for 86 diabetic patients and 106 non-diabetic patients presenting with acute PE was collected via retrospective chart review. Plasma levels of pro-inflammatory (C-reactive protein [CRP], tumor necrosis factor-alpha [TNF-α], interleukin-6 [IL-6]) and pro-thrombotic (d-dimer, plasminogen activator inhibitor-1 [PAI-1], tissue plasminogen activator [tPA], thrombin activatable fibrinolysis inhibitor [TAFI], von-Willebrand factor [vWF], endogenous glycosaminoglycans [GAGs]) biomarkers were drawn within 24 hours of diagnosis of acute PE. Data was also obtained for a population of healthy adult controls. All the pro-inflammatory and pro-thrombotic biomarkers were elevated in diabetic PE patients in comparison to healthy controls. None of the biomarkers were elevated in diabetic PE patients when compared to non-diabetic PE patients. There was no difference in the levels of the pro-inflammatory biomarkers according to glycemic control. The plasma level of TAFI was elevated in diabetic patients with poor glycemic control. Diabetic patients were more likely to have a more severe PE. These studies demonstrate that thrombo-inflammatory biomarkers are elevated in diabetic PE patients with associated comorbidities in comparison to normal individuals. However, there is no difference between the PE cohort alone in comparison to PE with diabetes. The role of TAFI within the continuum of diabetic vascular disease warrants additional investigation.
    MeSH term(s) Adult ; Humans ; Tissue Plasminogen Activator ; Diabetes Mellitus, Type 2/complications ; Retrospective Studies ; Glycemic Control ; Pulmonary Embolism/complications ; Biomarkers ; Thrombosis/complications ; Plasminogen Activator Inhibitor 1 ; Carboxypeptidase B2 ; Fibrinolysis
    Chemical Substances Tissue Plasminogen Activator (EC 3.4.21.68) ; Biomarkers ; Plasminogen Activator Inhibitor 1 ; Carboxypeptidase B2 (EC 3.4.17.20)
    Language English
    Publishing date 2023-03-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1237357-6
    ISSN 1938-2723 ; 1076-0296
    ISSN (online) 1938-2723
    ISSN 1076-0296
    DOI 10.1177/10760296231165058
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top